Mobile diabetes tracker app from Glooko gets FDA approval

Glooko, a Silicon Valley startup, received 510(k) clearance from the FDA for its smartphone application that allows diabetics to collect and view information needed to help them monitor their blood glucose levels, according to TechCrunch. With regulatory approval as a Class 2 device, Glooko is now free to sell its solution in the U.S. -- previously it was only available in Europe. Users download blood glucose meter results to an iOS smartphone and then obtain insight into the effect their daily activities have on these numbers. Glooko is compatible with more than 17 different glucose meters. Article

Suggested Articles

The newly launched Center for Connected Health will be largest telehealth hub in the Philadelphia region, according to Penn Medicine.

The FDA commissioner wants to use additional funding under Trump's budget to advance digital health initiatives and integrate real-world data.

The FDA's approval of an app that uses AI to notify specialists of a potential stroke offers new possibilities for triage software that uses CDS.